Skip to main content
PMC home page
Philosophical Transactions of the Royal Society B: Biological Sciences logoLink to Philosophical Transactions of the Royal Society B: Biological Sciences
. 1999 Dec 29;354(1392):1995–2010. doi: 10.1098/rstb.1999.0539

From genotype to phenotype: genetics and medical practice in the new millennium.

D Weatherall 1
PMCID: PMC1692700  PMID: 10670020

Abstract

The completion of the human genome project will provide a vast amount of information about human genetic diversity. One of the major challenges for the medical sciences will be to relate genotype to phenotype. Over recent years considerable progress has been made in relating the molecular pathology of monogenic diseases to the associated clinical phenotypes. Studies of the inherited disorders of haemoglobin, notably the thalassaemias, have shown how even in these, the simplest of monogenic diseases, there is remarkable complexity with respect to their phenotypic expression. Although studies of other monogenic diseases are less far advanced, it is clear that the same level of complexity will exist. This information provides some indication of the difficulties that will be met when trying to define the genes that are involved in common multigenic disorders and, in particular, in trying to relate disease phenotypes to the complex interactions between many genes and multiple environmental factors.

Full Text

The Full Text of this article is available as a PDF (259.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen S. J., O'Donnell A., Alexander N. D., Alpers M. P., Peto T. E., Clegg J. B., Weatherall D. J. alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14736–14741. doi: 10.1073/pnas.94.26.14736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ashley C. T., Jr, Warren S. T. Trinucleotide repeat expansion and human disease. Annu Rev Genet. 1995;29:703–728. doi: 10.1146/annurev.ge.29.120195.003415. [DOI] [PubMed] [Google Scholar]
  3. Balmain A., Nagase H. Cancer resistance genes in mice: models for the study of tumour modifiers. Trends Genet. 1998 Apr;14(4):139–144. doi: 10.1016/s0168-9525(98)01422-x. [DOI] [PubMed] [Google Scholar]
  4. Beggs A. H., Neumann P. E., Arahata K., Arikawa E., Nonaka I., Anderson M. S., Kunkel L. M. Possible influences on the expression of X chromosome-linked dystrophin abnormalities by heterozygosity for autosomal recessive Fukuyama congenital muscular dystrophy. Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):623–627. doi: 10.1073/pnas.89.2.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cassidy S. B. Prader-Willi syndrome. J Med Genet. 1997 Nov;34(11):917–923. doi: 10.1136/jmg.34.11.917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Coleman R., Genet S. A., Harper J. I., Wilkie A. O. Interaction of incontinentia pigmenti and factor VIII mutations in a female with biased X inactivation, resulting in haemophilia. J Med Genet. 1993 Jun;30(6):497–500. doi: 10.1136/jmg.30.6.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Craig J. E., Rochette J., Fisher C. A., Weatherall D. J., Marc S., Lathrop G. M., Demenais F., Thein S. Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach. Nat Genet. 1996 Jan;12(1):58–64. doi: 10.1038/ng0196-58. [DOI] [PubMed] [Google Scholar]
  8. Craig J. E., Rochette J., Sampietro M., Wilkie A. O., Barnetson R., Hatton C. S., Demenais F., Thein S. L. Genetic heterogeneity in heterocellular hereditary persistence of fetal hemoglobin. Blood. 1997 Jul 1;90(1):428–434. [PubMed] [Google Scholar]
  9. DiSilvestre D., Koch R., Groffen J. Different clinical manifestations of hyperphenylalaninemia in three siblings with identical phenylalanine hydroxylase genes. Am J Hum Genet. 1991 May;48(5):1014–1016. [PMC free article] [PubMed] [Google Scholar]
  10. Dover G. J., Smith K. D., Chang Y. C., Purvis S., Mays A., Meyers D. A., Sheils C., Serjeant G. Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2. Blood. 1992 Aug 1;80(3):816–824. [PubMed] [Google Scholar]
  11. Efremov D. G., Dimovski A. J., Baysal E., Ye Z., Adekile A. D., Ribeiro M. L., Schiliro G., Altay C., Gürgey A., Efremov G. D. Possible factors influencing the haemoglobin and fetal haemoglobin levels in patients with beta-thalassaemia due to a homozygosity for the IVS-I-6 (T-->C) mutation. Br J Haematol. 1994 Apr;86(4):824–830. doi: 10.1111/j.1365-2141.1994.tb04837.x. [DOI] [PubMed] [Google Scholar]
  12. Flint J., Harding R. M., Boyce A. J., Clegg J. B. The population genetics of the haemoglobinopathies. Baillieres Clin Haematol. 1998 Mar;11(1):1–51. doi: 10.1016/s0950-3536(98)80069-3. [DOI] [PubMed] [Google Scholar]
  13. Galanello R., Dessi E., Melis M. A., Addis M., Sanna M. A., Rosatelli C., Argiolu F., Giagu N., Turco M. P., Cacace E. Molecular analysis of beta zero-thalassemia intermedia in Sardinia. Blood. 1989 Aug 1;74(2):823–827. [PubMed] [Google Scholar]
  14. Galanello R., Perseu L., Melis M. A., Cipollina L., Barella S., Giagu N., Turco M. P., Maccioni O., Cao A. Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome. Br J Haematol. 1997 Nov;99(2):433–436. doi: 10.1046/j.1365-2141.1997.3703182.x. [DOI] [PubMed] [Google Scholar]
  15. Gibbons R. J., Picketts D. J., Villard L., Higgs D. R. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome). Cell. 1995 Mar 24;80(6):837–845. doi: 10.1016/0092-8674(95)90287-2. [DOI] [PubMed] [Google Scholar]
  16. Gilman J. G., Huisman T. H. DNA sequence variation associated with elevated fetal G gamma globin production. Blood. 1985 Oct;66(4):783–787. [PubMed] [Google Scholar]
  17. Hawkes C. H. Twin studies in medicine--what do they tell us? QJM. 1997 May;90(5):311–321. doi: 10.1093/qjmed/90.5.311. [DOI] [PubMed] [Google Scholar]
  18. Higgs D. R. alpha-Thalassaemia. Baillieres Clin Haematol. 1993 Mar;6(1):117–150. doi: 10.1016/s0950-3536(05)80068-x. [DOI] [PubMed] [Google Scholar]
  19. Ho P. J., Hall G. W., Luo L. Y., Weatherall D. J., Thein S. L. Beta-thalassaemia intermedia: is it possible consistently to predict phenotype from genotype? Br J Haematol. 1998 Jan;100(1):70–78. doi: 10.1046/j.1365-2141.1998.00519.x. [DOI] [PubMed] [Google Scholar]
  20. Ho P. J., Hall G. W., Watt S., West N. C., Wimperis J. W., Wood W. G., Thein S. L. Unusually severe heterozygous beta-thalassemia: evidence for an interacting gene affecting globin translation. Blood. 1998 Nov 1;92(9):3428–3435. [PubMed] [Google Scholar]
  21. Jarvi K., Zielenski J., Wilschanski M., Durie P., Buckspan M., Tullis E., Markiewicz D., Tsui L. C. Cystic fibrosis transmembrane conductance regulator and obstructive azoospermia. Lancet. 1995 Jun 17;345(8964):1578–1578. doi: 10.1016/s0140-6736(95)91131-6. [DOI] [PubMed] [Google Scholar]
  22. Joslyn G., Carlson M., Thliveris A., Albertsen H., Gelbert L., Samowitz W., Groden J., Stevens J., Spirio L., Robertson M. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell. 1991 Aug 9;66(3):601–613. doi: 10.1016/0092-8674(81)90022-2. [DOI] [PubMed] [Google Scholar]
  23. Kajiwara K., Berson E. L., Dryja T. P. Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. Science. 1994 Jun 10;264(5165):1604–1608. doi: 10.1126/science.8202715. [DOI] [PubMed] [Google Scholar]
  24. Kerem E., Corey M., Kerem B. S., Rommens J., Markiewicz D., Levison H., Tsui L. C., Durie P. The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). N Engl J Med. 1990 Nov 29;323(22):1517–1522. doi: 10.1056/NEJM199011293232203. [DOI] [PubMed] [Google Scholar]
  25. Kinzler K. W., Nilbert M. C., Su L. K., Vogelstein B., Bryan T. M., Levy D. B., Smith K. J., Preisinger A. C., Hedge P., McKechnie D. Identification of FAP locus genes from chromosome 5q21. Science. 1991 Aug 9;253(5020):661–665. doi: 10.1126/science.1651562. [DOI] [PubMed] [Google Scholar]
  26. Knox-Macaulay H. H., Weatherall D. J., Clegg J. B., Pembrey M. E. Thalassaemia in the British. Br Med J. 1973 Jul 21;3(5872):150–155. doi: 10.1136/bmj.3.5872.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Labie D., Pagnier J., Lapoumeroulie C., Rouabhi F., Dunda-Belkhodja O., Chardin P., Beldjord C., Wajcman H., Fabry M. E., Nagel R. L. Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients. Proc Natl Acad Sci U S A. 1985 Apr;82(7):2111–2114. doi: 10.1073/pnas.82.7.2111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Latham T., Grabowski G. A., Theophilus B. D., Smith F. I. Complex alleles of the acid beta-glucosidase gene in Gaucher disease. Am J Hum Genet. 1990 Jul;47(1):79–86. [PMC free article] [PubMed] [Google Scholar]
  29. Leppert M., Burt R., Hughes J. P., Samowitz W., Nakamura Y., Woodward S., Gardner E., Lalouel J. M., White R. Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N Engl J Med. 1990 Mar 29;322(13):904–908. doi: 10.1056/NEJM199003293221306. [DOI] [PubMed] [Google Scholar]
  30. Lightowlers R. N., Chinnery P. F., Turnbull D. M., Howell N. Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet. 1997 Nov;13(11):450–455. doi: 10.1016/s0168-9525(97)01266-3. [DOI] [PubMed] [Google Scholar]
  31. Mendez M., Sorkin L., Rossetti M. V., Astrin K. H., del C Batlle A. M., Parera V. E., Aizencang G., Desnick R. J. Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles. Am J Hum Genet. 1998 Nov;63(5):1363–1375. doi: 10.1086/302119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Nicholls R. D., Saitoh S., Horsthemke B. Imprinting in Prader-Willi and Angelman syndromes. Trends Genet. 1998 May;14(5):194–200. doi: 10.1016/s0168-9525(98)01432-2. [DOI] [PubMed] [Google Scholar]
  33. Rees D. C., Singh B. M., Luo L. Y., Wickramasinghe S., Thein S. L. Nontransfusional iron overload in thalassemia. Association with hereditary hemochromatosis. Ann N Y Acad Sci. 1998 Jun 30;850:490–494. doi: 10.1111/j.1749-6632.1998.tb10530.x. [DOI] [PubMed] [Google Scholar]
  34. Rees D. C., Styles L., Vichinsky E. P., Clegg J. B., Weatherall D. J. The hemoglobin E syndromes. Ann N Y Acad Sci. 1998 Jun 30;850:334–343. doi: 10.1111/j.1749-6632.1998.tb10490.x. [DOI] [PubMed] [Google Scholar]
  35. Rund D., Oron-Karni V., Filon D., Goldfarb A., Rachmilewitz E., Oppenheim A. Genetic analysis of beta-thalassemia intermedia in Israel: diversity of mechanisms and unpredictability of phenotype. Am J Hematol. 1997 Jan;54(1):16–22. doi: 10.1002/(sici)1096-8652(199701)54:1<16::aid-ajh3>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  36. Sampietro M., Lupica L., Perrero L., Comino A., Martinez di Montemuros F., Cappellini M. D., Fiorelli G. The expression of uridine diphosphate glucuronosyltransferase gene is a major determinant of bilirubin level in heterozygous beta-thalassaemia and in glucose-6-phosphate dehydrogenase deficiency. Br J Haematol. 1997 Nov;99(2):437–439. doi: 10.1046/j.1365-2141.1997.4113228.x. [DOI] [PubMed] [Google Scholar]
  37. Sampietro M., Piperno A., Lupica L., Arosio C., Vergani A., Corbetta N., Malosio I., Mattioli M., Fracanzani A. L., Cappellini M. D. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology. 1998 Jan;27(1):181–184. doi: 10.1002/hep.510270128. [DOI] [PubMed] [Google Scholar]
  38. Sinden R. R. Biological implications of the DNA structures associated with disease-causing triplet repeats. Am J Hum Genet. 1999 Feb;64(2):346–353. doi: 10.1086/302271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Skuse D. H., James R. S., Bishop D. V., Coppin B., Dalton P., Aamodt-Leeper G., Bacarese-Hamilton M., Creswell C., McGurk R., Jacobs P. A. Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. Nature. 1997 Jun 12;387(6634):705–708. doi: 10.1038/42706. [DOI] [PubMed] [Google Scholar]
  40. Summers K. M. Relationship between genotype and phenotype in monogenic diseases: relevance to polygenic diseases. Hum Mutat. 1996;7(4):283–293. doi: 10.1002/(SICI)1098-1004(1996)7:4<283::AID-HUMU1>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
  41. Tamagnini G. P., Lopes M. C., Castanheira M. E., Wainscoat J. S., Wood W. G. Beta + thalassemia--Portuguese type: clinical, haematological and molecular studies of a newly defined form of beta thalassaemia. Br J Haematol. 1983 Jun;54(2):189–200. doi: 10.1111/j.1365-2141.1983.tb02087.x. [DOI] [PubMed] [Google Scholar]
  42. Thein S. L., Hesketh C., Taylor P., Temperley I. J., Hutchinson R. M., Old J. M., Wood W. G., Clegg J. B., Weatherall D. J. Molecular basis for dominantly inherited inclusion body beta-thalassemia. Proc Natl Acad Sci U S A. 1990 May;87(10):3924–3928. doi: 10.1073/pnas.87.10.3924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Thein S. L., Wainscoat J. S., Sampietro M., Old J. M., Cappellini D., Fiorelli G., Modell B., Weatherall D. J. Association of thalassaemia intermedia with a beta-globin gene haplotype. Br J Haematol. 1987 Mar;65(3):367–373. doi: 10.1111/j.1365-2141.1987.tb06870.x. [DOI] [PubMed] [Google Scholar]
  44. Thein S. L., Weatherall D. J. A non-deletion hereditary persistence of fetal hemoglobin (HPFH) determinant not linked to the beta-globin gene complex. Prog Clin Biol Res. 1989;316B:97–111. [PubMed] [Google Scholar]
  45. Todd J. A. From genome to aetiology in a multifactorial disease, type 1 diabetes. Bioessays. 1999 Feb;21(2):164–174. doi: 10.1002/(SICI)1521-1878(199902)21:2<164::AID-BIES10>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
  46. Wallace D. C. Mitochondrial diseases in man and mouse. Science. 1999 Mar 5;283(5407):1482–1488. doi: 10.1126/science.283.5407.1482. [DOI] [PubMed] [Google Scholar]
  47. Weatherall D. J., Clegg J. B., Knox-Macaulay H. H., Bunch C., Hopkins C. R., Temperley I. J. A genetically determined disorder with features both of thalassaemia and congenital dyserythropoietic anaemia. Br J Haematol. 1973 Jun;24(6):681–702. doi: 10.1111/j.1365-2141.1973.tb01696.x. [DOI] [PubMed] [Google Scholar]
  48. Weatherall D. J., Clegg J. B., Naughton M. A. Globin synthesis in thalassaemia: an in vitro study. Nature. 1965 Dec 11;208(5015):1061–1065. doi: 10.1038/2081061a0. [DOI] [PubMed] [Google Scholar]
  49. Weatherall D. J., Clegg J. B., Wood W. G., Old J. M., Higgs D. R., Pressley L., Darbre P. D. The clinical and molecular heterogeneity of the thalassemia syndromes. Ann N Y Acad Sci. 1980;344:83–100. doi: 10.1111/j.1749-6632.1980.tb33652.x. [DOI] [PubMed] [Google Scholar]
  50. Weatherall D. J., Higgs D. R., Bunch C., Old J. M., Hunt D. M., Pressley L., Clegg J. B., Bethlenfalvay N. C., Sjolin S., Koler R. D. Hemoglobin H disease and mental retardation: a new syndrome or a remarkable coincidence? N Engl J Med. 1981 Sep 10;305(11):607–612. doi: 10.1056/NEJM198109103051103. [DOI] [PubMed] [Google Scholar]
  51. Weatherall D. J. Pathophysiology of thalassaemia. Baillieres Clin Haematol. 1998 Mar;11(1):127–146. doi: 10.1016/s0950-3536(98)80072-3. [DOI] [PubMed] [Google Scholar]
  52. Weatherall D. J. Thalassemia in the next millennium. Keynote address. Ann N Y Acad Sci. 1998 Jun 30;850:1–9. doi: 10.1111/j.1749-6632.1998.tb10456.x. [DOI] [PubMed] [Google Scholar]
  53. Weatherall D., Clegg J., Kwiatkowski D. The role of genomics in studying genetic susceptibility to infectious disease. Genome Res. 1997 Oct;7(10):967–973. doi: 10.1101/gr.7.10.967. [DOI] [PubMed] [Google Scholar]
  54. Wilkie A. O., Buckle V. J., Harris P. C., Lamb J., Barton N. J., Reeders S. T., Lindenbaum R. H., Nicholls R. D., Barrow M., Bethlenfalvay N. C. Clinical features and molecular analysis of the alpha thalassemia/mental retardation syndromes. I. Cases due to deletions involving chromosome band 16p13.3. Am J Hum Genet. 1990 Jun;46(6):1112–1126. [PMC free article] [PubMed] [Google Scholar]
  55. Wilkie A. O., Zeitlin H. C., Lindenbaum R. H., Buckle V. J., Fischel-Ghodsian N., Chui D. H., Gardner-Medwin D., MacGillivray M. H., Weatherall D. J., Higgs D. R. Clinical features and molecular analysis of the alpha thalassemia/mental retardation syndromes. II. Cases without detectable abnormality of the alpha globin complex. Am J Hum Genet. 1990 Jun;46(6):1127–1140. [PMC free article] [PubMed] [Google Scholar]
  56. Williams T. N., Maitland K., Bennett S., Ganczakowski M., Peto T. E., Newbold C. I., Bowden D. K., Weatherall D. J., Clegg J. B. High incidence of malaria in alpha-thalassaemic children. Nature. 1996 Oct 10;383(6600):522–525. doi: 10.1038/383522a0. [DOI] [PubMed] [Google Scholar]
  57. Wolf U. Identical mutations and phenotypic variation. Hum Genet. 1997 Sep;100(3-4):305–321. doi: 10.1007/s004390050509. [DOI] [PubMed] [Google Scholar]
  58. Wonke B. Bone disease in beta-thalassaemia major. Br J Haematol. 1998 Dec;103(4):897–901. doi: 10.1046/j.1365-2141.1998.01107.x. [DOI] [PubMed] [Google Scholar]

Articles from Philosophical Transactions of the Royal Society B: Biological Sciences are provided here courtesy of The Royal Society

RESOURCES